Clinical Trial Update: Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 trial of ulixertinib with hydroxychloroquine for advanced gastrointestinal cancers was terminated, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Ulixertinib (ulixertinib)

Snippet

Sponsor: BioMed Valley Discoveries, Inc | Conditions: Tumor, Solid, Gastrointestinal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-09-25